Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
GENOCEA BIOSCIENCES, INC. (GNCA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/27/2022 |
SC 13D/A
| New Enterprise Associates 16, L.P. has filed a Schedule 13D for Genocea Biosciences, Inc. |
| 04/13/2021 |
SC 13D/A
| New Enterprise Associates 16, L.P. reports a 26.3% stake in Genocea Biosciences, Inc. |
| 08/03/2020 |
SC 13D/A
| New Enterprise Associates 16, L.P. reports a 48.7% stake in Genocea Biosciences, Inc. |
| 06/28/2019 |
SC 13D/A
| New Enterprise Associates 16, L.P. reports a 34.1% stake in Genocea Biosciences, Inc. |
| 02/22/2019 |
SC 13D/A
| New Enterprise Associates 16, L.P. reports a 49.1% stake in Genocea Biosciences, Inc. |
| 02/14/2019 |
SC 13D/A
| Polaris Venture Partners V, L.P. reports a 2.3% stake in GENOCEA BIOSCIENCES, INC. |
| 02/13/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
|
|